- C052P: Polatuzumab Biosimilar, CD79B Monoclonal Antibody - Recombinant Humanized IgG1 Monoclonal Antibody. 
 Specificity/Sensitivity: The research grade polatuzumab biosimilar specifically binds to the CD79B protein.
 Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by polatuzumab.